Clinical Trial

TAVI in LOW RISK in the REAL WORLD

Study acronym: TAVI IN LOW R
Completed
View on ClinicalTrials.gov →
Summary
The primary objective is to assess all-cause mortality, the occurrence of stroke, or rehospitalization for cardiovascular causes in low-risk "all-comers" patients following percutaneous aortic valve replacement
Trial Details
NCT Number NCT07605780
Lead Sponsor Centro Cardiologico Monzino
Collaborators: Fondazione Poliambulanza Istituto Ospedaliero
Conditions Aortic Valve Stenosis
Enrollment 650 participants
Start Date 2024-12-13
Primary Completion 2025-08-24 (estimated)
Study Completion 2025-08-24 (estimated)
Updated on ClinicalTrials.gov 2026-05-26